Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1987 Jul;58(1):72–77. doi: 10.1136/hrt.58.1.72

Prosthetic valve endocarditis. A survey.

M Ben Ismail, N Hannachi, F Abid, Z Kaabar, J F Rougé
PMCID: PMC1277250  PMID: 3620246

Abstract

Fifty eight patients (aged 8-59 years, mean 27) treated for prosthetic valve endocarditis from January 1966 to January 1985 were studied retrospectively by review of case notes. There were 12 cases of early and 46 cases of late prosthetic valve endocarditis. These developed in 28 patients with an isolated aortic valve, in 26 with an isolated mitral valve, and in four with both aortic and mitral prosthetic valves. Streptococci were the most commonly isolated microorganisms, followed by staphylococci, Gram negative bacteria, and fungi. A surgical (34 cases) or a necropsy specimen (10 cases) from 44 cases was examined. Eighty two per cent of the patients had congestive heart failure. Twenty four of the 58 patients were medically treated and 17 died (70% mortality). Combined medical and surgical treatment was used in 34 patients; the main indication for surgery was congestive heart failure. Fourteen patients on combined treatment died (40% mortality). Persistent sepsis and prosthetic valve dehiscence were the most common early and late operative complications. The most important influences on outcome were congestive heart failure, the type of micro-organism, the severity and extent of anatomical lesions, the time of onset of prosthetic valve endocarditis, and the type of treatment. This survey indicates that only patients without congestive heart failure or embolic complications and with sensitive micro-organism should be treated medically. In view of the poor prognosis patients with prosthetic valve endocarditis associated with congestive heart failure, persistent sepsis, and repeat arterial emboli should be treated by early surgical intervention.

Full text

PDF
72

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. J., Bulkley B. H., Hutchins G. M. A clinicopathologic study of prosthetic valve endocarditis in 22 patients: morphologic basis for diagnosis and therapy. Am Heart J. 1977 Sep;94(3):325–332. doi: 10.1016/s0002-8703(77)80475-4. [DOI] [PubMed] [Google Scholar]
  2. Auger P., Marquis G., Dyrda I., Martineau J. P., Solymoss C. B. Infective endocarditis update experience from a heart hospital. Acta Cardiol. 1981;36(2):105–123. [PubMed] [Google Scholar]
  3. Baumgartner W. A., Miller D. C., Reitz B. A., Oyer P. E., Jamieson S. W., Stinson E. B., Shumway N. E. Surgical treatment of prosthetic valve endocarditis. Ann Thorac Surg. 1983 Jan;35(1):87–104. doi: 10.1016/s0003-4975(10)61436-1. [DOI] [PubMed] [Google Scholar]
  4. Calderwood S. B., Swinski L. A., Waternaux C. M., Karchmer A. W., Buckley M. J. Risk factors for the development of prosthetic valve endocarditis. Circulation. 1985 Jul;72(1):31–37. doi: 10.1161/01.cir.72.1.31. [DOI] [PubMed] [Google Scholar]
  5. Carson D. A., Bayer A. S., Eisenberg R. A., Lawrance S., Theofilopoulos A. IgG rheumatoid factor in subacute bacterial endocarditis: relationship to IgM rheumatoid factor and circulating immune complexes. Clin Exp Immunol. 1978 Jan;31(1):100–103. [PMC free article] [PubMed] [Google Scholar]
  6. Dismukes W. E., Karchmer A. W., Buckley M. J., Austen W. G., Swartz M. N. Prosthetic valve endocarditis. Analysis of 38 cases. Circulation. 1973 Aug;48(2):365–377. doi: 10.1161/01.cir.48.2.365. [DOI] [PubMed] [Google Scholar]
  7. Ferrans V. J., Boyce S. W., Billingham M. E., Spray T. L., Roberts W. C. Infection of glutaraldehyde-preserved porcine valve heterografts. Am J Cardiol. 1979 Jun;43(6):1123–1136. doi: 10.1016/0002-9149(79)90143-7. [DOI] [PubMed] [Google Scholar]
  8. Herreman G., Godeau P., Cabane J., Acar J. F., Digeon M., Bach J. F. Complexes immuns circulants et endocardites infectieuses. A propos de 64 observations. Ann Med Interne (Paris) 1978 Jun-Jul;129(6-7):387–397. [PubMed] [Google Scholar]
  9. Ivert T. S., Dismukes W. E., Cobbs C. G., Blackstone E. H., Kirklin J. W., Bergdahl L. A. Prosthetic valve endocarditis. Circulation. 1984 Feb;69(2):223–232. doi: 10.1161/01.cir.69.2.223. [DOI] [PubMed] [Google Scholar]
  10. Karchmer A. W., Dismukes W. E., Buckley M. J., Austen W. G. Late prosthetic valve endocarditis: clinical features influencing therapy. Am J Med. 1978 Feb;64(2):199–206. doi: 10.1016/0002-9343(78)90046-3. [DOI] [PubMed] [Google Scholar]
  11. Madison J., Wang K., Gobel F. L., Edwards J. E. Prosthetic aortic valvular endocarditis. Circulation. 1975 May;51(5):940–949. doi: 10.1161/01.cir.51.5.940. [DOI] [PubMed] [Google Scholar]
  12. Magilligan D. J., Jr, Quinn E. L., Davila J. C. Bacteremia, endocarditis, and the Hancock valve. Ann Thorac Surg. 1977 Dec;24(6):508–518. doi: 10.1016/s0003-4975(10)63449-2. [DOI] [PubMed] [Google Scholar]
  13. Masur H., Johnson W. D., Jr Prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1980 Jul;80(1):31–37. [PubMed] [Google Scholar]
  14. Morel-Maroger L., Sraer J. D., Herreman G., Godeau P. Kidney in subacute endocarditis. Pathological and immunofluorescence findings. Arch Pathol. 1972 Sep;94(3):205–213. [PubMed] [Google Scholar]
  15. Núez L., de la Llana R., Aguado M. G., Iglesias A., Larrea J. L., Celemín D. Bioprosthetic valve endocarditis: indicators for surgical intervention. Ann Thorac Surg. 1983 Mar;35(3):262–270. doi: 10.1016/s0003-4975(10)61555-x. [DOI] [PubMed] [Google Scholar]
  16. Rossiter S. J., Stinson E. B., Oyer P. E., Miller D. C., Schapira J. N., Martin R. P., Shumway N. E. Prosthetic valve endocarditis. Comparison of heterograft tissue valves and mechanical valves. J Thorac Cardiovasc Surg. 1978 Dec;76(6):795–803. [PubMed] [Google Scholar]
  17. Slaughter L., Morris J. E., Starr A. Prosthetic valvular endocarditis. A 12-year review. Circulation. 1973 Jun;47(6):1319–1326. doi: 10.1161/01.cir.47.6.1319. [DOI] [PubMed] [Google Scholar]
  18. Stinson E. B., Copeland J. G., Shumway N. E. Operative treatment of active endocarditis. J Thorac Cardiovasc Surg. 1976 May;71(5):659–665. [PubMed] [Google Scholar]
  19. Sweeney M. S., Reul G. J., Jr, Cooley D. A., Ott D. A., Duncan J. M., Frazier O. H., Livesay J. J. Comparison of bioprosthetic and mechanical valve replacement for active endocarditis. J Thorac Cardiovasc Surg. 1985 Nov;90(5):676–680. [PubMed] [Google Scholar]
  20. Vahanian A., Prost J. F., Richard C., Dewilde J., Acar J. Endocardites infectieuses chez les porteurs de prothèses valvulaires. Arch Mal Coeur Vaiss. 1982 Sep;75(9):971–979. [PubMed] [Google Scholar]
  21. Wilson W. R., Jaumin P. M., Danielson G. K., Giuliani E. R., Washington JA I. I., Geraci J. E. Prosthetic valve endocarditis. Ann Intern Med. 1975 Jun;82(6):751–756. doi: 10.7326/0003-4819-82-6-751. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES